These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26465382)

  • 1. Parts per Million Powder X-ray Diffraction.
    Newman JA; Schmitt PD; Toth SJ; Deng F; Zhang S; Simpson GJ
    Anal Chem; 2015 Nov; 87(21):10950-5. PubMed ID: 26465382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of X-ray powder diffraction and solid-state nuclear magnetic resonance in estimating crystalline fraction of tacrolimus in sustained-release amorphous solid dispersion and development of discriminating dissolution method.
    Rahman Z; Bykadi S; Siddiqui A; Khan MA
    J Pharm Sci; 2015 May; 104(5):1777-86. PubMed ID: 25753829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.
    Zidan AS; Rahman Z; Sayeed V; Raw A; Yu L; Khan MA
    Int J Pharm; 2012 Feb; 423(2):341-50. PubMed ID: 22100517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly sensitive solid forms discrimination on the whole tablet of the active ingredients in quercetin dietary supplements by NMR crystallography approaches.
    Miclaus MO; Filip X; Filip C; Martin FA; Grosu IG
    J Pharm Biomed Anal; 2016 May; 124():274-280. PubMed ID: 26970982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear optical imaging for sensitive detection of crystals in bulk amorphous powders.
    Kestur US; Wanapun D; Toth SJ; Wegiel LA; Simpson GJ; Taylor LS
    J Pharm Sci; 2012 Nov; 101(11):4201-13. PubMed ID: 22847843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel methods for the assessment of miscibility of amorphous drug-polymer dispersions.
    Ivanisevic I; Bates S; Chen P
    J Pharm Sci; 2009 Sep; 98(9):3373-86. PubMed ID: 19283767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calibration-Free Second Harmonic Generation (SHG) Image Analysis for Quantification of Trace Crystallinity Within Final Dosage Forms of Amorphous Solid Dispersions.
    Smith CJ; Dinh J; Schmitt PD; Stroud PA; Hinds J; Johnson MJ; Simpson GJ
    Appl Spectrosc; 2018 Nov; 72(11):1594-1605. PubMed ID: 29896972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical stability studies of miscible amorphous solid dispersions.
    Ivanisevic I
    J Pharm Sci; 2010 Sep; 99(9):4005-12. PubMed ID: 20533553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Data fusion of Fourier transform infrared spectra and powder X-ray diffraction patterns for pharmaceutical mixtures.
    Haware RV; Wright PR; Morris KR; Hamad ML
    J Pharm Biomed Anal; 2011 Dec; 56(5):944-9. PubMed ID: 21873013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying API polymorphs in formulations using X-ray powder diffraction and multivariate standard addition method combined with net analyte signal analysis.
    Zappi A; Maini L; Galimberti G; Caliandro R; Melucci D
    Eur J Pharm Sci; 2019 Mar; 130():36-43. PubMed ID: 30654113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic Modeling of Accelerated Stability Testing Enabled by Second Harmonic Generation Microscopy.
    Song Z; Sarkar S; Vogt AD; Danzer GD; Smith CJ; Gualtieri EJ; Simpson GJ
    Anal Chem; 2018 Apr; 90(7):4406-4413. PubMed ID: 29505717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New applications of electron diffraction in the pharmaceutical industry: polymorph determination by using a combination of electron diffraction and synchrotron X-ray powder diffraction techniques.
    Li ZG; Harlow RL; Foris CM; Li H; Ma P; Vickery RD; Maurin MB; Toby BH
    Microsc Microanal; 2002 Apr; 8(2):134-8. PubMed ID: 12533242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of net analyte signal orthogonalization in the separation of multi-component diffraction patterns obtained from X-ray powder diffraction of intact compacts.
    Moore MD; Cogdill RP; Short SM; Hair CR; Wildfong PL
    J Pharm Biomed Anal; 2008 Jun; 47(2):238-47. PubMed ID: 18294800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes.
    Yan YD; Sung JH; Kim KK; Kim DW; Kim JO; Lee BJ; Yong CS; Choi HG
    Int J Pharm; 2012 Jan; 422(1-2):202-10. PubMed ID: 22085435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel white film for pharmaceutical coating formed by interaction of calcium lactate pentahydrate with hydroxypropyl methylcellulose.
    Sakata Y; Shiraishi S; Otsuka M
    Int J Pharm; 2006 Jul; 317(2):120-6. PubMed ID: 16621357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of trace crystallinity in an amorphous system using Raman microscopy and chemometric analysis.
    Widjaja E; Kanaujia P; Lau G; Ng WK; Garland M; Saal C; Hanefeld A; Fischbach M; Maio M; Tan RB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):45-54. PubMed ID: 20969956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct derivation of the crystalline fraction of highly potent active pharmaceutical ingredients by X-ray powder diffraction.
    Dall'Olio L; Spinozzi S; Curzi M; Modena E; Maini L
    Eur J Pharm Sci; 2021 Apr; 159():105692. PubMed ID: 33373746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural characterization of iron oxide/hydroxide nanoparticles in nine different parenteral drugs for the treatment of iron deficiency anaemia by electron diffraction (ED) and X-ray powder diffraction (XRPD).
    Fütterer S; Andrusenko I; Kolb U; Hofmeister W; Langguth P
    J Pharm Biomed Anal; 2013 Dec; 86():151-60. PubMed ID: 23998966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.